Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Palisade Bio, Inc.
Palisade Bio Announces Early Exercise of Warrants Resulting in Cash Proceeds of $1.25 Million
December 07, 2022
From
Palisade Bio, Inc.
Via
GlobeNewswire
Tickers
PALI
Palisade Bio Regains Compliance with Nasdaq Listing Requirements
December 01, 2022
From
Palisade Bio, Inc.
Via
GlobeNewswire
Tickers
PALI
Palisade Bio is Granted Fast Track Designation from the U.S. Food and Drug Administration for LB1148 for Accelerated Return of Bowel Function following GI Surgery
November 22, 2022
From
Palisade Bio, Inc.
Via
GlobeNewswire
Tickers
PALI
Palisade Bio Appoints Herbert B. Slade, MD, FAAAAI as Chief Medical Officer
November 18, 2022
From
Palisade Bio, Inc.
Via
GlobeNewswire
Tickers
PALI
Palisade Bio Releases In-Depth Explanation of Scientific Approach of Lead Product Candidate LB1148 Through Animated Video
November 17, 2022
From
Palisade Bio, Inc.
Via
GlobeNewswire
Tickers
PALI
Palisade Bio Announces Reverse Stock Split
November 15, 2022
From
Palisade Bio, Inc.
Via
GlobeNewswire
Tickers
PALI
Palisade Bio Reports Third Quarter 2022 Financial Results and Provides Business Update
November 14, 2022
From
Palisade Bio, Inc.
Via
GlobeNewswire
Tickers
PALI
Palisade Bio Announces Executive Leadership Transition
October 11, 2022
From
Palisade Bio, Inc.
Via
GlobeNewswire
Tickers
PALI
Palisade Bio Announces Oral Presentation of Phase 2 Data at the American College of Surgeons (ACS) Clinical Congress 2022
September 29, 2022
From
Palisade Bio, Inc.
Via
GlobeNewswire
Tickers
PALI
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.